Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 25, 2015

Primary Completion Date

December 21, 2016

Study Completion Date

December 21, 2016

Conditions

Retinal Vein OcclusionAge Related Macular Degeneration

Interventions

DRUG

Ranibizumab Intravitreal injections

Ranibizumab intravitreal injections 3 months 1 per month and after PRN treatment.

Trial Locations (1)

Novartis Investigative Site, Providencia